Related Experiment Video
Updated: Jul 11, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Recent advances in stroke management
G W Albers1, M J Alberts, J P Broderick
1Stanford University Medical University, Palo Alto, CA, USA.
Recent stroke research highlights effective risk factor modification for prevention and introduces intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke treatment within 3 hours. While neuroprotective agents show promise, rapid administration is key for all acute stroke therapies.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Pharmacology
Background:
- Stroke incidence can be substantially reduced through modification of identified risk factors.
- Emerging risk factors include elevated plasma homocysteine, antiphospholipid antibodies, and genetic factors.
- Intravenous tissue plasminogen activator (t-PA) is the sole FDA-approved acute ischemic stroke treatment.
Purpose of the Study:
- To review recent advances in stroke treatment and prevention.
- To discuss the efficacy and challenges of current acute stroke therapies, including t-PA.
- To explore the potential of neuroprotective agents and the importance of rapid treatment administration.
Main Methods:
- Review of recent studies on stroke risk factors and treatment modalities.
- Analysis of clinical trial outcomes for thrombolytic and neuroprotective agents.
- Discussion of the development of acute stroke teams for timely intervention.
Main Results:
- Modification of stroke risk factors significantly reduces stroke incidence.
- Intravenous t-PA is effective for acute ischemic stroke if administered within 3 hours, though its risks and benefits require careful consideration.
- Neuroprotective agents have shown limited success in human clinical trials despite promising animal model results.
Conclusions:
- Rapid administration of both thrombolytic and neuroprotective treatments is crucial for acute stroke management.
- The development of specialized acute stroke teams is essential for facilitating prompt diagnosis and treatment.
- Ongoing research into novel neuroprotective agents and improved clinical trial designs holds promise for future therapeutic breakthroughs.
Related Concept Videos
Atherosclerosis IV: Nursing Management
Ischemic Stroke ll: Pathophysiology
Acute Coronary Syndrome IV: Interprofessional Care
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
